# FDA 483 - Dharma Research, Inc. - March 13, 2026

Source: https://www.keypedia.com/records/483/dharma-research-inc/556a67cb-8fb7-4255-b4b3-cb762b88d7d8

> FDA 483 for Dharma Research, Inc. on March 13, 2026. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Dharma Research, Inc.
- Inspection Date: 2026-03-13
- Product Type: other
- Office Name: Florida District Office
- Summary: An FDA inspection of Dharma Research, Inc., a manufacturer in Miami, FL, identified one observation. The firm was cited for inadequately documenting its risk management processes. Specifically, potential risks associated with Jade etchant gels, such as vomiting and diarrhea, were not properly identified in the Failure Mode and Effects Analysis Worksheet.

## Related Documents

- [483 - 2019-03-18](https://www.keypedia.com/records/483/dharma-research-inc/9001697c-9f9f-49e2-b674-4c4f2b6f1ecd)
- [483 - 2022-09-30](https://www.keypedia.com/records/483/dharma-research-inc/eff499fd-5fd4-4762-952b-88439345a244)
- [483 - 2024-12-11](https://www.keypedia.com/records/483/dharma-research-inc/8c6be09a-ff38-4125-97e6-2d24ef168c87)

## Related Officers

- [investigator](https://www.keypedia.com/people/ronald-ifraimov/b4ce8b79-3fa2-4862-b7a4-68e14e45d87a)

Company: https://www.keypedia.com/companies/dharma-research-inc/548c3b8a-f5b8-4b54-a899-a23f794fd666

Office: https://www.keypedia.com/offices/florida-district-office/95b2a118-0b78-46e0-a54c-982bd7ce51c9